Extended NeuroAmides

PRECLINICAL
PHASE 1
PHASE 2
PHASE 3
PRE
P1
P2
P3
Edit

Updated: 08/27/2019

Pipeline Type

New Drugs in Development

Phase Of Development

Preclinical

Sponsors and Collaborators

Neurogate Therapeutics, Epilepsy Foundation (EF)

Mechanism of Action

Ion Channel

Mechanism Description

modulate sodium channels

Populations Tested In

N/A

Other Resources

Special FDA Designation

Nonprofit or Government Support

Nonprofit

Nonprofit or Government Support Description

Epilepsy Foundation - SEAL 2013

Previous Presentations

Presented at meetings (latest date) (Pipeline, AEDD; AES, Eilat, etc)
N/A

Location of Clinical Trials

N/A

Clinical Trial link

Sign Up for Emails

Stay up to date with the latest epilepsy news, stories from the community, and more.